Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT01672866

Public ClinicalTrials.gov record NCT01672866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like Molecule 2 (LOXL2), in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate whether SIM (formerly referred to as GS-6624) is effective at preventing the histologic progression of liver fibrosis and the clinical progression to cirrhosis in participants with NASH. It will consist of 2 phases: * Randomized Double-Blind Phase * Open-Label Phase (optional)

Study identification

NCT ID
NCT01672866
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
222 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2012 (Actual)
Primary completion
Aug 2, 2016 (Actual)
Completion
Dec 29, 2016 (Actual)
Last update posted
Mar 27, 2019

2012 – 2016

United States locations

U.S. sites
41
U.S. states
25
U.S. cities
37
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054 —
Southern California Liver Centers Coronado California 92118 —
University of California, San Diego (UCSD) San Diego California 92103 —
University of California San Francisco (UCSF) San Francisco California 94143 —
University of Colorado Aurora Colorado 80045 —
Miami Veterans Administration Healthcare System Miami Florida 33136 —
Tampa General Hospital Tampa Florida 33606 —
Northwestern University Chicago Illinois 60611 —
Indianapolis Gastroenterology Research Foundation Indianapolis Indiana 46237 —
Iowa Digestive Disease Center Clive Iowa 50325 —
University of Louisville Louisville Kentucky 40202 —
Tulane University New Orleans Louisiana 70112 —
Mercy Medical Center Baltimore Maryland 21202 —
Walter Reed National Military Medical Center Bethesda Maryland 20889 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Lahey Clinic Burlington Massachusetts 01805 —
University of Michigan Ann Arbor Michigan 48109 —
Minnnesota Gastroenterology, PA Saint Paul Minnesota 55114 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Saint Louis University Hospital St Louis Missouri 63110 —
State University Of New York Buffalo New York 14203 —
Weill Cornell Medical College New York New York 10021 —
Mount Sinai Hospital New York New York 10029 —
Duke University Durham North Carolina 27710 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University Gastroenterology Providence Rhode Island 02905 —
Medical University of South Carolina Charleston South Carolina 29425 —
Texas Clinical Research Institute, LLC Arlington Texas 76012 —
Brooke Army Medical Center Fort Sam Houston Texas 78234 —
St. Luke's Episcopal Hospital Houston Texas 77030 —
Alamo Clinical Research Associates San Antonio Texas 78215 —
University of Utah Salt Lake City Utah 84132 —
University of Virginia Health System Charlottesville Virginia 22908 —
Liver Institute of Virginia Newport News Virginia 23602 —
Digestive and Liver Disease Specialists Norfolk Virginia 23502 —
Bucheon St. Marys Hospital Richmond Virginia 23229 —
Virginia Commonwealth University Health System Richmond Virginia 23298 —
Virginia Mason Medical Center Seattle Washington 98101 —
University of Washington Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01672866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01672866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →